Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Saved in:
| Title: | Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I). |
|---|---|
| Authors: | Gondry O; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Xavier C; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Raes L; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Heemskerk J; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Devoogdt N; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Everaert H; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Lecocq Q; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Decoster L; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Fontaine C; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Schallier D; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Aspeslagh S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Vaneycken I; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Raes G; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Van Ginderachter JA; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Lahoutte T; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Caveliers V; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Keyaerts M; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Sep; Vol. 64 (9), pp. 1378-1384. Date of Electronic Publication: 2023 Jul 20. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37474271 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I Study of [<superscript>68</superscript>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gondry+O%22">Gondry O</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Xavier+C%22">Xavier C</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Raes+L%22">Raes L</searchLink>; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Heemskerk+J%22">Heemskerk J</searchLink>; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Devoogdt+N%22">Devoogdt N</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Everaert+H%22">Everaert H</searchLink>; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Breckpot+K%22">Breckpot K</searchLink>; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Lecocq+Q%22">Lecocq Q</searchLink>; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Decoster+L%22">Decoster L</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Fontaine+C%22">Fontaine C</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Schallier+D%22">Schallier D</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Aspeslagh+S%22">Aspeslagh S</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vaneycken+I%22">Vaneycken I</searchLink>; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Raes+G%22">Raes G</searchLink>; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Ginderachter+JA%22">Van Ginderachter JA</searchLink>; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Lahoutte+T%22">Lahoutte T</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Caveliers+V%22">Caveliers V</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Keyaerts+M%22">Keyaerts M</searchLink>; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2023 Sep; Vol. 64 (9), pp. 1378-1384. <i>Date of Electronic Publication: </i>2023 Jul 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37474271 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.122.264853 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1378 Titles: – TitleFull: Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gondry O – PersonEntity: Name: NameFull: Xavier C – PersonEntity: Name: NameFull: Raes L – PersonEntity: Name: NameFull: Heemskerk J – PersonEntity: Name: NameFull: Devoogdt N – PersonEntity: Name: NameFull: Everaert H – PersonEntity: Name: NameFull: Breckpot K – PersonEntity: Name: NameFull: Lecocq Q – PersonEntity: Name: NameFull: Decoster L – PersonEntity: Name: NameFull: Fontaine C – PersonEntity: Name: NameFull: Schallier D – PersonEntity: Name: NameFull: Aspeslagh S – PersonEntity: Name: NameFull: Vaneycken I – PersonEntity: Name: NameFull: Raes G – PersonEntity: Name: NameFull: Van Ginderachter JA – PersonEntity: Name: NameFull: Lahoutte T – PersonEntity: Name: NameFull: Caveliers V – PersonEntity: Name: NameFull: Keyaerts M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 64 – Type: issue Value: 9 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |